☆ 4.8 Review

Modeling the crosstalk between malignant B cells and their microenvironment in B-cell lymphomas: challenges and opportunities

FRONTIERS IN IMMUNOLOGY (2023)

Related references

Note: Only part of the references are listed.

Review Oncology

Humanized mouse models for immuno-oncology research

Jane Chuprin et al.

Summary: Immunotherapy has shown promise in treating various cancers, but there is still much to learn about its mechanisms of action and biomarkers of response. Humanized mice, which are mice engrafted with human tumors and immune components, offer several advantages for immuno-oncology research. This Review discusses the benefits and challenges of humanized mice and highlights the latest advances in their generation for potential clinical translation.

NATURE REVIEWS CLINICAL ONCOLOGY (2023)

Add to Collection

Article Multidisciplinary Sciences

BTG1 mutation yields supercompetitive B cells primed for malignant transformation

Coraline Mlynarczyk et al.

Summary: Multicellular life relies on altruistic cooperation among cells. However, a study found that mutations in the BTG1 gene disrupt a crucial mechanism that limits B cell fitness during antibody affinity maturation, leading to the emergence of aggressive lymphomas.

SCIENCE (2023)

Add to Collection

Article Chemistry, Physical

Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomas

Shivem B. Shah et al.

Summary: Using synthetic-hydrogel-based organoids, researchers identified that cellular and biophysical factors in the lymphoid tumor microenvironment (Ly-TME) dampen the efficacy of targeted therapies for DLBCL. Combinatorial inhibition of multiple aberrant signaling pathways showed higher antitumor efficacy in lymphoid organoids and implanted patient tumors. These studies define the crosstalk between malignant ABC-DLBCL cells and Ly-TME and provide rational combinatorial therapies to overcome treatment resistance mediated by Ly-TME.

NATURE MATERIALS (2023)

Add to Collection

Article Multidisciplinary Sciences

KMT2D acetylation by CREBBP reveals a cooperative functional interaction at enhancers in normal and malignant germinal center B cells

Sofija Vlasevska et al.

Summary: Heterozygous inactivating mutations of KMT2D and CREBBP are common in B cell lymphoma, and they co-occur in a significant number of follicular lymphoma and EZB/C3 diffuse large B cell lymphoma cases. The combination of haploinsufficiency of Crebbp and Kmt2d promotes the expansion of abnormally polarized germinal centers, which is an early event in lymphoma development. These findings highlight the functional and biochemical interaction between Crebbp and Kmt2d, and its implications for the treatment of lymphomas with enhancer defects induced by their combined loss.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Add to Collection

Article Oncology

Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors

Joseph G. Schroers-Martin et al.

Summary: Follicular lymphomas (FL) are characterized by BCL2 translocations, often detectable in blood years before FL diagnosis, but also observed in aging healthy individuals, suggesting additional lesions are required for lymphomagenesis. CREBBP KAT domain mutations were the most commonly observed precursor lesions, distinguishing patients developing FL from healthy adults with or without BCL2 rearrangements. These mutations can be detected years before clinical diagnosis and may help discriminate individuals at risk for lymphoma development.

CANCER DISCOVERY (2023)

Add to Collection

Article Multidisciplinary Sciences

HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models

Hang Ke et al.

Summary: Both PD1/PD-L1 and CD47 blockades have limited activity in most subtypes of NHL, except for NK/T-cell lymphoma. The hemotoxicity of anti-CD47 agents in clinic may explain their limitations. In this study, a bispecific antibody HX009 was developed, targeting PD1 and CD47, with weakened CD47 binding to reduce toxicity. In vitro and in vivo experiments demonstrated the antitumor activity of HX009, especially in lymphomas with upregulated CD47. These findings support further clinical development of HX009 for NHL treatment.

SCIENTIFIC REPORTS (2023)

Add to Collection

Article Medicine, Research & Experimental

Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

Benedetta Apollonio et al.

Summary: Recent transcriptomic analysis has uncovered the clinical relevance of LN fibroblast and tumor-infiltrating lymphocyte (TIL) signatures in diffuse large B cell lymphoma (DLBCL). The study demonstrates that DLBCL activates fibroblastic reticular cells (FRCs) in the tumor microenvironment, leading to immunosuppression and inhibition of TIL migration and cytotoxicity. Inhibiting FRCs can enhance antilymphoma TIL cytotoxicity, suggesting the potential for immunotherapy optimization for DLBCL patients.

JOURNAL OF CLINICAL INVESTIGATION (2023)

Add to Collection

Review Immunology

Germinal Centers

Gabriel D. Victora et al.

Summary: This paper reviews recent developments in the field of germinal center (GC) biology, specifically in GCs induced by infection or immunization. It summarizes the phenotype and function of different cell types in the GC, focusing on GC B cells. It also examines the cellular and molecular basis of affinity-dependent selection within the GC and the export of memory and plasma cells. Additionally, it provides an overview of the emerging field of GC clonal dynamics and its impact on the diversity of antibodies secreted into serum.

ANNUAL REVIEW OF IMMUNOLOGY (2022)

Add to Collection

Article Hematology

The molecular ontogeny of follicular lymphoma: gene mutations succeeding the BCL2 translocation define common precursor cells

Sarah Haebe et al.

Summary: This study found that in relapsed follicular lymphoma, the BCL2/IGH translocation may precede CPC-defining mutations, and cells with BCL2/IGH translocation can persist in clinical remission.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Add to Collection

Article Oncology

SETD2 Haploinsufficiency Enhances Germinal Center-Associated AICDA Somatic Hypermutation to Drive B- cell Lymphomagenesis

Wilfred Leung et al.

Summary: SETD2 is a histone methyltransferase responsible for H3K36me3 and its mutation can lead to DNA damage and tumor development. Heterozygous deficiency of Setd2 results in germinal center hyperplasia and increased competitive fitness, accelerating lymphomagenesis. SETD2 deficiency impairs DNA damage sensing and repair, leading to increased gene mutations and translocations.

CANCER DISCOVERY (2022)

Add to Collection

Article Biotechnology & Applied Microbiology

Development and Characterization of 3D Hybrid Spheroids for the Investigation of the Crosstalk Between B-Cell Non-Hodgkin Lymphomas and Mesenchymal Stromal Cells

Kamila Dus-Szachniewicz et al.

Summary: This study developed a reproducible 3D model for studying the interaction between B-NHL cells and MSCs. The conditions for spheroid formation were optimized, and co-culturing B-NHL cells with MSCs significantly reduced apoptosis induced by a specific anti-cancer drug.

ONCOTARGETS AND THERAPY (2022)

Add to Collection

Article Oncology

Distinct B-Cell Specific Transcriptional Contexts of the BCL2 Oncogene Impact Pre-Malignant Development in Mouse Models

Lina Zawil et al.

Summary: BCL2 is a commonly deregulated gene in various B-cell malignancies, and its deregulation may have different impacts on B-cell fate. This study designed two transgenic mouse models to compare the effects of BCL2 association with IgH3'RR and Ig kappa gene loci on B-cell fate and lymphoid tissues. The results showed that BCL2 association with IgH3'RR primarily impacted germinal center B-cell populations, while its association with Ig kappa locus primarily boosted the influx of plasma cells and the accumulation of long-lived plasma cells.

CANCERS (2022)

Add to Collection

Article Immunology

Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas

Devin Dersh et al.

Summary: Genome-wide screening in diffuse large B cell lymphomas identified genes that modulate MHC-I cell surface expression in multiple pathways. These genes represent potential targets for manipulating MHC-I immunosurveillance in cancers and other diseases. Pharmacological inhibition of negative regulators of antigen presentation enhanced MHC-I presentation in DLBCL.

IMMUNITY (2021)

Add to Collection

Review Immunology

Development and Immunological Function of Lymph Node Stromal Cells

Natalia Barbara Pikor et al.

Summary: Stromal cells in lymph nodes play a crucial role in supporting immune cell interactions by providing a tailored mixture of niche factors. Recent advances in genetic models and transcriptomic analyses have revealed the strategic positioning of distinct stromal cell subsets for efficient immune responses. Activation of poised stromal cell-supported niches, rather than differentiation of new subsets, governs the interaction of immune cells during adaptive immune responses.

JOURNAL OF IMMUNOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture

Nevin Yusufova et al.

Summary: Mutations in histone H1 play a significant role in driving malignant transformation in lymphomas through remodeling of chromatin structure, leading to changes in epigenetic states and de-repression of developmentally silenced genes. This study establishes H1 as a tumor suppressor and highlights its involvement in three-dimensional genome reorganization, ultimately contributing to aggressive lymphomas with increased repopulating potential.

NATURE (2021)

Add to Collection

Article Oncology

Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures

Nikita Kotlov et al.

Summary: In this study, a transcriptomic analysis of the microenvironment of DLBCL was conducted, revealing four major lymphoma microenvironment categories associated with distinct biological aberrations and clinical behavior. This research also identified genetic and epigenetic mechanisms used by cancer cells to evade microenvironmental constraints and suggested the use of DNA hypomethylating agents in selected DLBCL patients. Additionally, new therapeutic vulnerabilities in the extracellular matrix composition were uncovered, providing potential targets for decreasing DLBCL proliferation in preclinical models.

CANCER DISCOVERY (2021)

Add to Collection

Article Immunology

Developing a 3D B Cell Lymphoma Culture System to Model Antibody Therapy

Russell Foxall et al.

Summary: DLBCL is a common type of NHL with a significant proportion of cases showing long-term remission with current first-line treatment. However, patients with primary refractory disease or early relapse have a poor prognosis, emphasizing the need for alternative therapies. A novel 3D spheroid co-culture system comprising key components of the DLBCL TME has been developed, exhibiting potential as a testbed for novel therapeutics.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Immunology

Advances in Human Immune System Mouse Models for Studying Human Hematopoiesis and Cancer Immunotherapy

Syed A. Mian et al.

Summary: Immunotherapy shows promise in cancer treatment, yet challenges remain, including the lack of suitable mouse models. Improved immunodeficient mice offer opportunities for comprehensive evaluation of therapeutic strategies and advancement in human hematopoietic research.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Cell Biology

Lymphocyte access to lymphoma is impaired by high endothelial venule regression

Lutz Menzel et al.

Summary: The study demonstrates that lymphoma leads to severe regression of high endothelial venules (HEVs) in the lymph nodes, disrupting immune cell trafficking and interactions in the microenvironment. This cascade of events involves the disruption of the lymph-carrying conduit system, deregulation of CCL21 migration paths, and loss of lymphotoxin-beta-receptor (LTbR) signaling, ultimately affecting HEV differentiation and lymphocyte transmigration.

CELL REPORTS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Functional heterogeneity of cytotoxic T cells and tumor resistance to cytotoxic hits limit anti-tumor activity in vivo

Roxana Khazen et al.

Summary: The majority of CTL interactions with tumor cells either in vitro or in vivo result in sublethal hits, which are associated with reversible calcium elevation and membrane damage in the target cells. In the therapeutic context of anti-CD19 CAR T cells, most interactions with tumor cells do not lead to lethal hit delivery. Differences in CTL lytic potential and tumor cell resistance to cytotoxic hits are two important barriers for effective anti-tumor responses in vivo.

EMBO JOURNAL (2021)

Add to Collection

Review Immunology

Bone Marrow Lymphoid Niche Adaptation to Mature B Cell Neoplasms

Erwan Dumontet et al.

Summary: The complexity of B-cell non-Hodgkin lymphoma (B-NHL) evolution and treatment lies in the high prevalence of relapses caused by the interaction between malignant B cells and tumor-supportive lymph node and bone marrow microenvironments. Targeting the crosstalk between bone marrow stromal cells and malignant B cells is crucial for preventing relapses in B-cell lymphomas.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Hematology

A novel 3D culture model recapitulates primary FL B-cell features and promotes their survival

Claire Lamaison et al.

Summary: The study developed a new tunable 3D model that successfully mimicked the microenvironment of B-cell lymphomas, aiding in the study of the dynamic relationship between tumor cells and their surroundings and screening for new anti-cancer drugs.

BLOOD ADVANCES (2021)

Add to Collection

Article Oncology

3D Model Characterization by 2D and 3D Imaging in t(14;18)-Positive B-NHL: Perspectives for In Vitro Drug Screens in Follicular Lymphoma

Fabien Gava et al.

Summary: Follicular lymphoma is an incurable type of B cell lymphoproliferative disorder, accounting for a significant percentage of NHL cases. The development of a realistic 3D model offers a promising approach for testing new therapeutic targets.

CANCERS (2021)

Add to Collection

Article Immunology

A cross-talk between CAR T cell subsets and the tumor microenvironment is essential for sustained cytotoxic activity

Morgane Boulch et al.

Summary: Chimeric antigen receptor (CAR) T cell therapy relies on interactions with the tumor microenvironment (TME) for optimal activity, with IFN-gamma playing a crucial role in enhancing host immune response and sustaining CAR T cell cytotoxicity. CAR T cell-derived IFN-gamma facilitates host interleukin-12 production to support host immune and CAR T cell responses, highlighting the importance of cytokine-mediated cross-talk for effective CAR T cell therapy.

SCIENCE IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Follicular lymphoma triggers phenotypic and functional remodeling of the human lymphoid stromal cell landscape

Frederic Mourcin et al.

Summary: The study identified three distinct human lymphoid stromal cell (LSC) subsets with different functions in healthy tissue. In lymphoma, LSCs can be reprogrammed in response to cytokines like tumor necrosis factor and transforming growth factor beta, leading to increased expression of chemokines. This bidirectional crosstalk between LSCs and malignant B cells may be a targetable axis in lymphoma.

IMMUNITY (2021)

Add to Collection

Review Immunology

B cell/stromal cell crosstalk in health, disease, and treatment: Follicular lymphoma as a paradigm

Claire Lamaison et al.

Summary: Stromal cells in bone marrow and lymphoid organs function to regulate B cell behavior, with follicular lymphoma being a prime example of a B-cell neoplasia dependent on a specific tumor microenvironment that includes cancer-associated fibroblasts (CAFs). This interaction between malignant B cells and stromal cells contributes to the complexity of the tumor microenvironment and highlights the need for further research into signaling pathways and molecular mechanisms for potential therapeutic targets.

IMMUNOLOGICAL REVIEWS (2021)

Add to Collection

Review Immunology

Human B Lymphomas Reveal Their Secrets Through Genetic Mouse Models

Noushin Mossadegh-Keller et al.

Summary: Lymphomas are cancers derived from lymphocytes and preferentially arise in secondary lymphoid organs, representing the 6th most common cancer worldwide. Most B cell Non-Hodgkin lymphomas develop from germinal center experienced mature B cells, with the differentiation steps in the GC being at the origin of frequent B cell malignant entities.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis

Yao-Hui Huang et al.

Summary: Epigenetic alterations, especially mutations in genes related to histone modification, play a crucial role in tumor progression of DLBCL by influencing the tumor microenvironment, leading to increased tumor cell proliferation and polarization of M2 macrophages.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomas

Yasuyuki Otsuka et al.

MOLECULAR IMMUNOLOGY (2020)

Add to Collection

Article Oncology

Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response

Wendy Beguelin et al.

CANCER CELL (2020)

Add to Collection

Article Oncology

Cathepsin S Regulates Antigen Processing and T Cell Activity in Non-Hodgkin Lymphoma

Elie Dheilly et al.

CANCER CELL (2020)

Add to Collection

Article Cell Biology

Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma

Deepak Bararia et al.

CELL REPORTS (2020)

Add to Collection

Review Immunology

Mouse Models ofc-mycDeregulation Driven by IgH Locus Enhancers as Models of B-Cell Lymphomagenesis

Melissa Ferrad et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Review Oncology

How the ageing microenvironment influences tumour progression

Mitchell Fane et al.

NATURE REVIEWS CANCER (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker release

Pooja Sabhachandani et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Add to Collection

Article Multidisciplinary Sciences

S-Geranylgeranyl-L-glutathione is a ligand for human B cell-confinement receptor P2RY8

Erick Lu et al.

NATURE (2019)

Add to Collection

Article Oncology

Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition

Daisuke Ennishi et al.

CANCER DISCOVERY (2019)

Add to Collection

Article Oncology

Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents

Chen Lossos et al.

CANCER DISCOVERY (2019)

Add to Collection

Article Immunology

The HVEM-BTLA Axis Restrains T Cell Help to Germinal Center B Cells and Functions as a Cell-Extrinsic Suppressor in Lymphomagenesis

Michelle A. Mintz et al.

IMMUNITY (2019)

Add to Collection

Article Immunology

Unique and Shared Epigenetic Programs of the CREBBP and EP300 Acetyltransferases in Germinal Center B Cells Reveal Targetable Dependencies in Lymphoma

Stefanie N. Meyer et al.

IMMUNITY (2019)

Add to Collection

Article Immunology

A Tridimensional Model for NK Cell-Mediated ADCC of Follicular Lymphoma

Emilie Decaup et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Article Oncology

Boosting γδ T cell-mediated antibody-dependent cellular cytotoxicity by PD-1 blockade in follicular lymphoma

Cedric Rossi et al.

ONCOIMMUNOLOGY (2019)

Add to Collection

Article Endocrinology & Metabolism

Oncogenic Rag GTPase signalling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR

Ana Ortega-Molina et al.

NATURE METABOLISM (2019)

Add to Collection

Review Engineering, Biomedical

Design of spherically structured 3D in vitro tumor models -Advances and prospects

L. P. Ferreira et al.

ACTA BIOMATERIALIA (2018)

Add to Collection

Article Hematology

Mechanisms of resistance to EZH2 inhibitors in diffuse large B-cell lymphomas

Malik Bisserier et al.

BLOOD (2018)

Add to Collection

Review Hematology

Microenvironment signaling driving lymphomagenesis

Lea Verdiere et al.

CURRENT OPINION IN HEMATOLOGY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells

Margherita Norelli et al.

NATURE MEDICINE (2018)

Add to Collection

Article Biochemical Research Methods

A human immune system mouse model with robust lymph node development

Yan Li et al.

NATURE METHODS (2018)

Add to Collection

Article Cell Biology

How Biophysical Forces Regulate Human B Cell Lymphomas

F. Apoorva et al.

CELL REPORTS (2018)

Add to Collection

Article Oncology

MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis

Paola Brescia et al.

CANCER CELL (2018)

Add to Collection

Review Oncology

From genetics to the clinic: a translational perspective on follicular lymphoma

Sarah Huet et al.

NATURE REVIEWS CANCER (2018)

Add to Collection

Article Oncology

CTLA-4 Limits Anti-CD20-Mediated Tumor Regression

Zhenhua Ren et al.

CLINICAL CANCER RESEARCH (2017)

Add to Collection

Article Oncology

CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas

Yanwen Jiang et al.

CANCER DISCOVERY (2017)

Add to Collection

Article Engineering, Biomedical

Award Winner in the Young Investigator Category, 2017 Society for Biomaterials Annual Meeting and Exposition, Minneapolis, MN, April 0508, 2017: Lymph node stiffness-mimicking hydrogels regulate human B-cell lymphoma growth and cell surface receptor expression in a molecular subtype-specific manner

F. N. U. Apoorva et al.

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2017)

Add to Collection

Article Multidisciplinary Sciences

Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth

Hind Hashwah et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Add to Collection

Article Cell Biology

Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma

Elisa Oricchio et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Add to Collection

Article Multidisciplinary Sciences

EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop

Wendy Beguelin et al.

NATURE COMMUNICATIONS (2017)

Add to Collection

Article Oncology

The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma

Jiyuan Zhang et al.

CANCER DISCOVERY (2017)

Add to Collection

Article Oncology

BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells

Ester Valls et al.

CANCER DISCOVERY (2017)

Add to Collection

Article Oncology

B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy

Leo Zhang et al.

CLINICAL CANCER RESEARCH (2017)

Add to Collection

Article Hematology

Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice

Idoia Garcia-Ramirez et al.

BLOOD (2017)

Add to Collection

Article Hematology

IL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma

Shubham Pandey et al.

BLOOD (2017)

Add to Collection

Article Genetics & Heredity

Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma

Jessica Okosun et al.

NATURE GENETICS (2016)

Add to Collection

Article Hematology

B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice

G. Knittel et al.

BLOOD (2016)

Add to Collection

Article Hematology

Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease

Bjoern Chapuy et al.

BLOOD (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells

Michael Boice et al.

CELL (2016)

Add to Collection

Article Biochemistry & Molecular Biology

An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation

George P. Souroullas et al.

NATURE MEDICINE (2016)

Add to Collection

Article Engineering, Biomedical

Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells

Ye F. Tian et al.

BIOMATERIALS (2015)

Add to Collection

Article Engineering, Biomedical

Ex vivo engineered immune organoids for controlled germinal center reactions

Alberto Purwada et al.

BIOMATERIALS (2015)

Add to Collection

Article Hematology

Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells

Adam Linley et al.

BLOOD (2015)

Add to Collection

Article Hematology

DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma

Rada Amin et al.

BLOOD (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis

Jiyuan Zhang et al.

NATURE MEDICINE (2015)

Add to Collection

Article Biochemistry & Molecular Biology

The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development

Ana Ortega-Molina et al.

NATURE MEDICINE (2015)

Add to Collection

Article Multidisciplinary Sciences

Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation

Michael R. Green et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Add to Collection

Article Multidisciplinary Sciences

Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cells

Keiki Sugimoto et al.

SCIENTIFIC REPORTS (2015)

Add to Collection

Article Chemistry, Physical

Light-triggered in vivo activation of adhesive peptides regulates cell adhesion, inflammation and vascularization of biomaterials

Ted T. Lee et al.

NATURE MATERIALS (2015)

Add to Collection

Review Immunology

Lymph node fibroblastic reticular cells in health and disease

Anne L. Fletcher et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Add to Collection

Review Immunology

Germinal centres and B cell lymphomagenesis

Katia Basso et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Add to Collection

Article Pathology

Cell Growth in Aggregates Determines Gene Expression, Proliferation, Survival, Chemoresistance, and Sensitivity to Immune Effectors in Follicular Lymphoma

Pauline Gravelle et al.

AMERICAN JOURNAL OF PATHOLOGY (2014)

Add to Collection

Article Medicine, Research & Experimental

Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression

Stephanie Sungalee et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Add to Collection

Article Oncology

t(14;18) Translocation: A Predictive Blood Biomarker for Follicular Lymphoma

Sandrine Roulland et al.

JOURNAL OF CLINICAL ONCOLOGY (2014)

Add to Collection

Article Immunology

Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy

Elisa Oricchio et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2014)

Add to Collection

Article Multidisciplinary Sciences

Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma

Jagan R. Muppidi et al.

NATURE (2014)

Add to Collection

Review Oncology

The tumour microenvironment in B cell lymphomas

David W. Scott et al.

NATURE REVIEWS CANCER (2014)

Add to Collection

Article Oncology

EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation

Wendy Beguelin et al.

CANCER CELL (2013)

Add to Collection

Article Medicine, Research & Experimental

Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis

Marieta Caganova et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Add to Collection

Article Biochemistry & Molecular Biology

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

Andrew J. Souers et al.

NATURE MEDICINE (2013)

Add to Collection

Article Oncology

Anti-tumor activity of obinutuzumab and rituximab in a follicular lymphoma 3D model

E. Decaup et al.

BLOOD CANCER JOURNAL (2013)

Add to Collection

Article Hematology

Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes

Fabien Guilloton et al.

BLOOD (2012)

Add to Collection

Article Oncology

Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells

P. Ame-Thomas et al.

LEUKEMIA (2012)

Add to Collection

Article Multidisciplinary Sciences

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

Michael T. McCabe et al.

NATURE (2012)

Add to Collection

Review Immunology

Stromal cell contribution to human follicular lymphoma pathogenesis

Frederic Mourcin et al.

FRONTIERS IN IMMUNOLOGY (2012)

Add to Collection

Article Hematology

Cooperative function of CCR7 and lymphotoxin in the formation of a lymphoma-permissive niche within murine secondary lymphoid organs

Armin Rehm et al.

BLOOD (2011)

Add to Collection

Article Biochemistry & Molecular Biology

The Eph-Receptor A7 Is a Soluble Tumor Suppressor for Follicular Lymphoma

Elisa Oricchio et al.

CELL (2011)

Add to Collection

Article Oncology

The immunoglobulin heavy chain gene 3′ enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells

H. Xiang et al.

LEUKEMIA (2011)

Add to Collection

Article Immunology

The sphingosine 1-phosphate receptor S1P2 maintains the homeostasis of germinal center B cells and promotes niche confinement

Jesse A. Green et al.

NATURE IMMUNOLOGY (2011)

Add to Collection

Article Hematology

Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a

Tint Lwin et al.

BLOOD (2010)

Add to Collection

Article Oncology

Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH-B cell axis

C. Pangault et al.

LEUKEMIA (2010)

Add to Collection

Article Hematology

T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy

Roch Houot et al.

BLOOD (2009)

Add to Collection

Article Hematology

Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20

David Dayde et al.

BLOOD (2009)

Add to Collection

Article Hematology

Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion

Roch Houot et al.

BLOOD (2009)

Add to Collection

Article Oncology

Targeted Disruption of the S1P2 Sphingosine 1-Phosphate Receptor Gene Leads to Diffuse Large B-Cell Lymphoma Formation

Giorgio Cattoretti et al.

CANCER RESEARCH (2009)

Add to Collection

Article Oncology

Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis

T. Lwin et al.

LEUKEMIA (2009)

Add to Collection

Article Medicine, General & Internal

Stromal Gene Signatures in Large-B-Cell Lymphomas

G. Lenz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Add to Collection

Article Immunology

Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells

Katsuto Takenaka et al.

NATURE IMMUNOLOGY (2007)

Add to Collection

Article Hematology

Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth:: role of stromal cells in follicular lymphoma pathogenesis

Patricia Ame-Thomas et al.

BLOOD (2007)

Add to Collection

Article Hematology

VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia

A Egle et al.

BLOOD (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.